Mutation Analysis of a Sandhoff Disease Patient in the Maronite Community in Cyprus

Overview

Journal Hum Genet

Specialty Genetics

Date 1994 Aug 1

PMID 8045559

Authors

Y Hara

P Ioannou

A Drousiotou

G Stylianidou

V Anastasiadou

K Suzuki

Affiliations

Soon will be listed here.

Abstract

Sandhoff disease occurs in the Christian Maronite community in Cyprus, a community that established over a thousand years ago. Nowadays, this community comprises less than 1% of the whole population, and has been culturally and socially isolated. Cultured fibroblasts from a patient from this inbred group showed a beta-hexosaminidase beta subunit mRNA of apparently the normal size but of reduced quantity. A mutational analysis of cDNA obtained by polymerase chain reaction amplification of mRNA showed a deletion of A at nt 76 (counted from A of the initiation codon, ATG). The deletion results in a frame shift and a premature termination within 20 amino acids from the N-terminus of the normal mature enzyme protein. The patient was homozygous for the deletion. The 5'-end of the gene showed many discrepancies from the previously published sequence. We consider that these differences are probably polymorphisms of little functional significance, because the patient's fibroblasts generate decreased but stable mRNA and because some of these base changes were also found in the genes from control fibroblasts. An extensive evaluation of the prevalence of this mutant allele in this community is being initiated.

References

Suzuki K, Vanier M . Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype. Dev Neurosci. 1991; 13(4-5):288-94. DOI: 10.1159/000112175. View

Navon R . Molecular and clinical heterogeneity of adult GM2 gangliosidosis. Dev Neurosci. 1991; 13(4-5):295-8. DOI: 10.1159/000112200. View

Neote K, Bapat B, Troxel C, Schuster S, Mahuran D, Gravel R . Characterization of the human HEXB gene encoding lysosomal beta-hexosaminidase. Genomics. 1988; 3(4):279-86. DOI: 10.1016/0888-7543(88)90116-4. View

Korneluk R, Mahuran D, Neote K, Klavins M, ODowd B, Tropak M . Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease. J Biol Chem. 1986; 261(18):8407-13. View

Ohno K, Suzuki K . A splicing defect due to an exon-intron junctional mutation results in abnormal beta-hexosaminidase alpha chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease. Biochem Biophys Res Commun. 1988; 153(1):463-9. DOI: 10.1016/s0006-291x(88)81247-6. View

Neote K, McInnes B, Mahuran D, Gravel R . Structure and distribution of an Alu-type deletion mutation in Sandhoff disease. J Clin Invest. 1990; 86(5):1524-31. PMC: 296899. DOI: 10.1172/JCI114871. View

Myerowitz R, Hogikyan N . Different mutations in Ashkenazi Jewish and non-Jewish French Canadians with Tay-Sachs disease. Science. 1986; 232(4758):1646-8. DOI: 10.1126/science.3754980. View

Myerowitz R . Splice junction mutation in some Ashkenazi Jews with Tay-Sachs disease: evidence against a single defect within this ethnic group. Proc Natl Acad Sci U S A. 1988; 85(11):3955-9. PMC: 280339. DOI: 10.1073/pnas.85.11.3955. View

SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

10.

Myerowitz R, Costigan F . The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase. J Biol Chem. 1988; 263(35):18587-9. View

11.

Proia R . Gene encoding the human beta-hexosaminidase beta chain: extensive homology of intron placement in the alpha- and beta-chain genes. Proc Natl Acad Sci U S A. 1988; 85(6):1883-7. PMC: 279885. DOI: 10.1073/pnas.85.6.1883. View

12.

dos Santos M, Tanaka A, Sa Miranda M, Ribeiro M, Maia M, Suzuki K . GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene mutations in 11 patients from a defined region in Portugal. Am J Hum Genet. 1991; 49(4):886-90. PMC: 1683169. View

13.

Der Kaloustian V, Khoury M, Hallal R, Idriss Z, Deeb M, Wakid N . Sandhoff disease: a prevalent form of infantile GM2 gangliosidosis in Lebanon. Am J Hum Genet. 1981; 33(1):85-9. PMC: 1684873. View

14.

Arpaia E, Maler T, Neote K, Tropak M, Troxel C, Stirling J . Identification of an altered splice site in Ashkenazi Tay-Sachs disease. Nature. 1988; 333(6168):85-6. DOI: 10.1038/333085a0. View

15.

Navon R, Proia R . The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease. Science. 1989; 243(4897):1471-4. DOI: 10.1126/science.2522679. View

16.

Vanier M, Ferlinz K, Rousson R, Duthel S, Louisot P, Sandhoff K . Deletion of arginine (608) in acid sphingomyelinase is the prevalent mutation among Niemann-Pick disease type B patients from northern Africa. Hum Genet. 1993; 92(4):325-30. DOI: 10.1007/BF01247328. View